Valrocemide
CAS: 92262-58-3
Ref. TM-T3562
| 5mg | 46.00 € | ||
| 10mg | 60.00 € | ||
| 25mg | 44.00 € | ||
| 50mg | 78.00 € | ||
| 100mg | 105.00 € | ||
| 1mL*10mM (DMSO) | 51.00 € |
Estimated delivery in United States, on Thursday 5 Dec 2024
Product Information
Name:
Valrocemide
Synonyms:
- TV1901
- N-Valproylglycinamide
- (1Beta,8Xi,11Beta,12Alpha,15Beta)-1,11,12-Trihydroxy-15-Methoxy-11,20-Epoxypicrasa-3,13(21)-Diene-2,16-Dione
- N-(2-Amino-2-oxoethyl)-2-propylpentanamide
- Pentanamide, N-(2-amino-2-oxoethyl)-2-propyl-
- Tv 1901
Description:
Valrocemide (TV1901), a broad-spectrum AED, is under development by Teva and Acorda for epilepsy treatment.
Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Targetmol
Long term storage:
Notes:
Chemical properties
Molecular weight:
200.28
Formula:
C10H20N2O2
Purity:
99.9%
Color/Form:
Solid
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:
Technical inquiry about: TM-T3562 Valrocemide
Please use instead the cart to request a quotation or an order
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
